The company, which specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), has installed a series of equipments at the centre, since its completion in April.
Besides these, employees at QLF carried various required procedures in May and June, which are vital to obtain GMP certification from SFDA.
Leveraging a multi-step process, including precipitation, filtration, centrifugation, concentration and purification, the pre-extraction facility will process, extract and purify TCM pharmaceutical ingredients from natural herbs and raw materials.
After this, the TCM pharma ingredients will be further formulated and integrated for the production of modernized products at the formulation facility.
Headquartered at Chengdu, China, TPI currently produces a complete suite of 58 products, 24 of which are listed in the highly selective national medicine reimbursement list, 10 are included in the essential drug list of China.